Tromsø, Norway

Johannes Eksteen


 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Johannes Eksteen

Introduction

Johannes Eksteen is a notable inventor based in Tromsø, Norway. He has made significant contributions to the field of biotechnology, particularly in the development of anti-lymphoma peptides. His work focuses on creating therapeutic agents that can combat tumors effectively.

Latest Patents

Johannes Eksteen holds a patent for his invention titled "Anti-lymphoma peptides." This invention provides a peptide that consists of 10 to 16 amino acids, featuring at least 8 cationic amino acids with specific side chains. The peptide also includes 2 or 3 tryptophan residues, which are strategically positioned. The invention extends to pharmaceutical compositions containing these peptides, emphasizing their use in therapy, especially as anti-tumor agents.

Career Highlights

Throughout his career, Johannes has been associated with prestigious institutions such as the University of Tromsø—Norwegian Arctic University. His research has contributed to advancements in therapeutic applications, particularly in oncology.

Collaborations

Johannes has collaborated with notable colleagues, including John Sigurd Svendsen and Øystein Rekdal. Their combined expertise has furthered the development of innovative solutions in the field of cancer treatment.

Conclusion

Johannes Eksteen's work exemplifies the impact of innovative research in biotechnology. His contributions to anti-lymphoma peptides highlight the potential for new therapeutic agents in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…